Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial. [PDF]
Mwesigwa N+9 more
europepmc +1 more source
Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort. [PDF]
Beach P, McKay JL.
europepmc +1 more source
Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges. [PDF]
Palma JA, Kaufmann H.
europepmc +1 more source
Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging? [PDF]
Palermo G+11 more
europepmc +1 more source
A Call to Action: The Role of Healthcare Providers in Reducing the Burden Associated with Neurogenic Orthostatic Hypotension. [PDF]
Gibson JS, Hunter CB, Hewitt LA.
europepmc +1 more source
The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension. [PDF]
Palma JA+7 more
europepmc +1 more source
Do we need to evaluate diastolic blood pressure in patients with suspected orthostatic hypotension? [PDF]
A Angelousi+35 more
core +1 more source
Abdominal compression in patients with neurogenic orthostatic hypotension
Phillip A. Low+7 more
openaire +2 more sources